Quantification of metronidazole in healthy subjects' feces using an LC–MS/MS method

A highly selective and sensitive liquid chromatography–tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid–liquid extraction with ethyl acetate and separated on Waters Symmetry® C18 (...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 32; no. 9; pp. e4265 - n/a
Main Authors Vanol, Pravin G., Sanyal, Mallika, Shah, Priyanka A., Shrivastav, Pranav S.
Format Journal Article
LanguageEnglish
Published England 01.09.2018
Subjects
Online AccessGet full text
ISSN0269-3879
1099-0801
1099-0801
DOI10.1002/bmc.4265

Cover

Loading…
Abstract A highly selective and sensitive liquid chromatography–tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid–liquid extraction with ethyl acetate and separated on Waters Symmetry® C18 (100 × 4.6 mm, 5μm) column using 0.1% formic acid in water and acetonitrile (40:60, v/v) as the mobile phase. A stable‐deuterated internal standard metronidazole‐d4 (MTZ‐d4) was used in the study. Mass analysis was performed on a triple quadrupole mass spectrometer in the positive electrospray ionization mode. A linear response function of MTZ was established in the concentration range of 0.50–250 ng/g, based on dry mass. The mean extraction recovery of MTZ (97.28%) and MTZ‐d4 (96.76%) from spiked feces samples was consistent at higher as well as lower concentrations. Post‐column infusion analysis showed no ion‐suppression/enhancement effects and the mean IS‐normalized matrix factor ranged from 0.986 to 1.013. Spiked feces samples stored at −20 and − 70°C for long‐term stability were stable for at least 3 months, while extracted samples (dry and wet extracts) were stable up to 24 h. The method was applied to determine MTZ in feces of 12 healthy Indian subjects.
AbstractList A highly selective and sensitive liquid chromatography-tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid-liquid extraction with ethyl acetate and separated on Waters Symmetry® C18 (100 × 4.6 mm, 5μm) column using 0.1% formic acid in water and acetonitrile (40:60, v/v) as the mobile phase. A stable-deuterated internal standard metronidazole-d4 (MTZ-d4) was used in the study. Mass analysis was performed on a triple quadrupole mass spectrometer in the positive electrospray ionization mode. A linear response function of MTZ was established in the concentration range of 0.50-250 ng/g, based on dry mass. The mean extraction recovery of MTZ (97.28%) and MTZ-d4 (96.76%) from spiked feces samples was consistent at higher as well as lower concentrations. Post-column infusion analysis showed no ion-suppression/enhancement effects and the mean IS-normalized matrix factor ranged from 0.986 to 1.013. Spiked feces samples stored at -20 and - 70°C for long-term stability were stable for at least 3 months, while extracted samples (dry and wet extracts) were stable up to 24 h. The method was applied to determine MTZ in feces of 12 healthy Indian subjects.A highly selective and sensitive liquid chromatography-tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid-liquid extraction with ethyl acetate and separated on Waters Symmetry® C18 (100 × 4.6 mm, 5μm) column using 0.1% formic acid in water and acetonitrile (40:60, v/v) as the mobile phase. A stable-deuterated internal standard metronidazole-d4 (MTZ-d4) was used in the study. Mass analysis was performed on a triple quadrupole mass spectrometer in the positive electrospray ionization mode. A linear response function of MTZ was established in the concentration range of 0.50-250 ng/g, based on dry mass. The mean extraction recovery of MTZ (97.28%) and MTZ-d4 (96.76%) from spiked feces samples was consistent at higher as well as lower concentrations. Post-column infusion analysis showed no ion-suppression/enhancement effects and the mean IS-normalized matrix factor ranged from 0.986 to 1.013. Spiked feces samples stored at -20 and - 70°C for long-term stability were stable for at least 3 months, while extracted samples (dry and wet extracts) were stable up to 24 h. The method was applied to determine MTZ in feces of 12 healthy Indian subjects.
A highly selective and sensitive liquid chromatography–tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid–liquid extraction with ethyl acetate and separated on Waters Symmetry® C18 (100 × 4.6 mm, 5μm) column using 0.1% formic acid in water and acetonitrile (40:60, v/v) as the mobile phase. A stable‐deuterated internal standard metronidazole‐d4 (MTZ‐d4) was used in the study. Mass analysis was performed on a triple quadrupole mass spectrometer in the positive electrospray ionization mode. A linear response function of MTZ was established in the concentration range of 0.50–250 ng/g, based on dry mass. The mean extraction recovery of MTZ (97.28%) and MTZ‐d4 (96.76%) from spiked feces samples was consistent at higher as well as lower concentrations. Post‐column infusion analysis showed no ion‐suppression/enhancement effects and the mean IS‐normalized matrix factor ranged from 0.986 to 1.013. Spiked feces samples stored at −20 and − 70°C for long‐term stability were stable for at least 3 months, while extracted samples (dry and wet extracts) were stable up to 24 h. The method was applied to determine MTZ in feces of 12 healthy Indian subjects.
A highly selective and sensitive liquid chromatography-tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid-liquid extraction with ethyl acetate and separated on Waters Symmetry® C (100 × 4.6 mm, 5μm) column using 0.1% formic acid in water and acetonitrile (40:60, v/v) as the mobile phase. A stable-deuterated internal standard metronidazole-d4 (MTZ-d4) was used in the study. Mass analysis was performed on a triple quadrupole mass spectrometer in the positive electrospray ionization mode. A linear response function of MTZ was established in the concentration range of 0.50-250 ng/g, based on dry mass. The mean extraction recovery of MTZ (97.28%) and MTZ-d4 (96.76%) from spiked feces samples was consistent at higher as well as lower concentrations. Post-column infusion analysis showed no ion-suppression/enhancement effects and the mean IS-normalized matrix factor ranged from 0.986 to 1.013. Spiked feces samples stored at -20 and - 70°C for long-term stability were stable for at least 3 months, while extracted samples (dry and wet extracts) were stable up to 24 h. The method was applied to determine MTZ in feces of 12 healthy Indian subjects.
A highly selective and sensitive liquid chromatography–tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ) in human feces. The analyte was recovered from feces after liquid–liquid extraction with ethyl acetate and separated on Waters Symmetry® C 18 (100 × 4.6 mm, 5μm) column using 0.1% formic acid in water and acetonitrile (40:60, v /v) as the mobile phase. A stable‐deuterated internal standard metronidazole‐d4 (MTZ‐d4) was used in the study. Mass analysis was performed on a triple quadrupole mass spectrometer in the positive electrospray ionization mode. A linear response function of MTZ was established in the concentration range of 0.50–250 ng/g, based on dry mass. The mean extraction recovery of MTZ (97.28%) and MTZ‐d4 (96.76%) from spiked feces samples was consistent at higher as well as lower concentrations. Post‐column infusion analysis showed no ion‐suppression/enhancement effects and the mean IS‐normalized matrix factor ranged from 0.986 to 1.013. Spiked feces samples stored at −20 and − 70°C for long‐term stability were stable for at least 3 months, while extracted samples (dry and wet extracts) were stable up to 24 h. The method was applied to determine MTZ in feces of 12 healthy Indian subjects.
Author Shah, Priyanka A.
Sanyal, Mallika
Vanol, Pravin G.
Shrivastav, Pranav S.
Author_xml – sequence: 1
  givenname: Pravin G.
  surname: Vanol
  fullname: Vanol, Pravin G.
  organization: Gujarat University
– sequence: 2
  givenname: Mallika
  surname: Sanyal
  fullname: Sanyal, Mallika
  organization: Gujarat University
– sequence: 3
  givenname: Priyanka A.
  surname: Shah
  fullname: Shah, Priyanka A.
  organization: St Xavier's College
– sequence: 4
  givenname: Pranav S.
  orcidid: 0000-0002-1284-1558
  surname: Shrivastav
  fullname: Shrivastav, Pranav S.
  email: pranav_shrivastav@yahoo.com
  organization: St Xavier's College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29679499$$D View this record in MEDLINE/PubMed
BookMark eNp10EtOwzAQgGELgaAFJE6AvINNyth52UuoeEmtEALWlutMqFFiQ5wIlRV34IachJTy2MDCms03Y-kfknXnHRKyx2DEAPjRrDajhGfpGhkwkDICAWydDIBnMopFLrfIMIQHAJAZzzfJFpdZLhMpB-TuutOutaU1urXeUV_SGtvGO1voF18htY7OUVftfEFDN3tA04YDWqLBQLtg3T3Vjk7G769v05uj6c1yee6LHbJR6irg7tfcJndnp7fji2hydX45Pp5EJuYsjeIk4QL7x00msMiYyHWuC0QhtIhRSp3kYDSIYlYabqTJDReyLIAlmsWpjrfJ4eruY-OfOgytqm0wWFXaoe-C4tD7FFKIe7r_RbtZjYV6bGytm4X6TtGD0QqYxofQYKmMbT-jtI22lWKglq1V31otW_9-_rPwffMPGq3os61w8a9TJ9Pxp_8AxwKNAA
CitedBy_id crossref_primary_10_1016_j_microc_2021_106379
crossref_primary_10_1016_j_diamond_2022_109303
crossref_primary_10_1016_j_jchromb_2019_121959
crossref_primary_10_1016_j_jchromb_2018_06_024
crossref_primary_10_1016_j_jchromb_2024_124057
Cites_doi 10.1016/j.clinbiochem.2016.11.031
10.1016/j.jpha.2012.02.007
10.1002/rcm.7158
10.1136/gut.27.10.1169
10.1136/jcp.34.6.645
10.1016/S0378-4347(98)00443-5
10.1002/bmc.4242
10.1016/j.jpba.2004.11.042
10.1016/S0378-4347(01)00334-6
10.2147/IDR.S119571
10.1080/10826070903430381
10.1093/chromsci/47.9.781
10.1016/j.jpba.2004.12.033
10.1016/j.microc.2017.08.008
10.2147/CIA.S149089
ContentType Journal Article
Copyright Copyright © 2018 John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2018 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1002/bmc.4265
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1099-0801
EndPage n/a
ExternalDocumentID 29679499
10_1002_bmc_4265
BMC4265
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23N
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AQPKS
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH5
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
RNS
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WRJ
WXSBR
WYISQ
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
7X8
ID FETCH-LOGICAL-c3215-34428e4282c68ed6187a7adee88a83e99a470ca08dbfc2c9c7c289fd014a135a3
IEDL.DBID DR2
ISSN 0269-3879
1099-0801
IngestDate Fri Jul 11 11:19:19 EDT 2025
Mon Jul 21 05:42:25 EDT 2025
Thu Apr 24 22:54:48 EDT 2025
Tue Jul 01 03:41:50 EDT 2025
Wed Jan 22 16:44:26 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords LC-MS/MS
metronidazole-d4
metronidazole
sensitive
human feces
healthy subjects
Language English
License Copyright © 2018 John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3215-34428e4282c68ed6187a7adee88a83e99a470ca08dbfc2c9c7c289fd014a135a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1284-1558
PMID 29679499
PQID 2028950503
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2028950503
pubmed_primary_29679499
crossref_citationtrail_10_1002_bmc_4265
crossref_primary_10_1002_bmc_4265
wiley_primary_10_1002_bmc_4265_BMC4265
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2018
PublicationDateYYYYMMDD 2018-09-01
PublicationDate_xml – month: 09
  year: 2018
  text: September 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Biomedical chromatography
PublicationTitleAlternate Biomed Chromatogr
PublicationYear 2018
References 2009; 33
2017; 50
2009; 47
2002; 59
2001; 761
2012; 2
2015; 29
2017; 10
2006; 14
1971; 26
2017; 12
1986; 27
2006; 5
1996
1998; 720
2015
2014
2005; 37
2018; 23
2005; 38
2017; 135
1981; 34
2012; 62
Mustapha K. B. (e_1_2_9_15_1) 2006; 5
e_1_2_9_20_1
e_1_2_9_11_1
e_1_2_9_22_1
e_1_2_9_10_1
e_1_2_9_21_1
e_1_2_9_13_1
e_1_2_9_24_1
Populaire P. (e_1_2_9_17_1) 1971; 26
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
Emami J. (e_1_2_9_7_1) 2006; 14
Klimowicz A. (e_1_2_9_12_1) 2002; 59
Freitas Silva M. (e_1_2_9_5_1) 2012; 62
e_1_2_9_9_1
e_1_2_9_14_1
e_1_2_9_16_1
e_1_2_9_19_1
e_1_2_9_18_1
References_xml – volume: 720
  start-page: 239
  issue: 1
  year: 1998
  end-page: 243
  article-title: Simple and sensitive method for determination of metronidazole in human serum by high‐performance liquid chromatography
  publication-title: Journal of Chromatography B: Biomedical Sciences and Applications
– volume: 12
  start-page: 1799
  year: 2017
  end-page: 1809
  article-title: infection in the elderly: An update on management
  publication-title: Clinical Interventions in Aging
– volume: 27
  start-page: 1169
  issue: 10
  year: 1986
  end-page: 1172
  article-title: Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to
  publication-title: Gut
– volume: 33
  start-page: 89
  issue: 1
  year: 2009
  end-page: 96
  article-title: Determination of metronidazole in adult Artemia using high performance liquid chromatography
  publication-title: Journal of Liquid Chromatography & Related Technologies
– volume: 5
  start-page: 1188
  year: 2006
  end-page: 1191
  article-title: Rapid, cost‐effective liquid chromatographic method for the determination of metronidazole in biological fluids
  publication-title: African Journal of Biotechnology
– volume: 62
  start-page: 490
  issue: 10
  year: 2012
  end-page: 495
  article-title: Metronidazole immediate release formulations: a fasting randomized open‐label crossover bioequivalence study in healthy volunteers
  publication-title: Arzneimittel‐Forschung
– volume: 26
  start-page: 581
  issue: 3
  year: 1971
  end-page: 594
  article-title: Circulation et sort du metronidazole dans de tractus digestif chez de rat apres administration par voie orale absorption du metronidazole per les muqueuses digestive
  publication-title: Thérapie
– volume: 10
  start-page: 365
  year: 2017
  end-page: 375
  article-title: Treatment of pediatric infection: A review on treatment efficacy and economic value
  publication-title: Infection and Drug Resistance
– volume: 23
  year: 2018
  article-title: Quantification of metronidazole in human plasma using a highly sensitive and rugged LC‐MS/MS method for a bioequivalence study
  publication-title: Biomedical Chromatography
– volume: 14
  start-page: 15
  issue: 1
  year: 2006
  end-page: 21
  article-title: A rapid and sensitive HPLC method for the analysis of metronidazole in human plasma: Application to single dose pharmacokinetic and bioequivalence studies
  publication-title: DARU Journal of Pharmaceutical Sciences
– year: 1996
– volume: 34
  start-page: 645
  issue: 6
  year: 1981
  end-page: 650
  article-title: Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals
  publication-title: Journal of Clinical Pathology
– volume: 135
  start-page: 81
  year: 2017
  end-page: 90
  article-title: Assessment of critical extraction and chromatographic parameters for the determination of bupropion and its three primary metabolites in human plasma by LC‐MS/MS
  publication-title: Microchemical Journal
– volume: 29
  start-page: 753
  issue: 8
  year: 2015
  end-page: 763
  article-title: Analysis of metronidazole in equine plasma using liquid chromatography/tandem mass spectrometry and high‐resolution accurate mass spectrometry
  publication-title: Rapid Communications in Mass Spectrometry
– volume: 2
  start-page: 378
  issue: 5
  year: 2012
  end-page: 381
  article-title: Determination of metronidazole in a rat stomach by HPLC for obtaining basic data of the eradication therapy of
  publication-title: Journal of Pharmaceutical Analysis
– year: 2014
– volume: 50
  start-page: 323
  issue: 6
  year: 2017
  end-page: 330
  article-title: Development and validation of a liquid chromatography tandem mass spectrometry assay for the measurement of faecal metronidazole
  publication-title: Clinical Biochemistry
– volume: 59
  start-page: 327
  issue: 5
  year: 2002
  end-page: 332
  article-title: A simple and rapid liquid chromatographic method for the determination of metronidazole and its hydroxymetabolite in plasma and cutaneous microdialysates
  publication-title: Acta Poloniae Pharmaceutica
– volume: 761
  start-page: 213
  year: 2001
  end-page: 219
  article-title: Quantification of metronidazole in small‐volume biological samples using narrow‐bore high‐performance liquid chromatography
  publication-title: Journal of Chromatography B: Biomedical Sciences and Applications
– volume: 37
  start-page: 777
  year: 2005
  end-page: 783
  article-title: Simultaneous determination of ranitidine and metronidazole in human plasma using high performance liquid chromatography with diode array detection
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 47
  start-page: 781
  issue: 9
  year: 2009
  end-page: 784
  article-title: Development and validation of a HPLC‐MS‐MS method for quantification of metronidazole in human plasma
  publication-title: Journal of Chromatographic Science
– year: 2015
– volume: 38
  start-page: 298
  issue: 2
  year: 2005
  end-page: 306
  article-title: Simultaneous determination of metronidazole and spiramycin I in human plasma, saliva and gingival crevicular fluid by LC‐MS/MS
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 5
  start-page: 1188
  year: 2006
  ident: e_1_2_9_15_1
  article-title: Rapid, cost‐effective liquid chromatographic method for the determination of metronidazole in biological fluids
  publication-title: African Journal of Biotechnology
– ident: e_1_2_9_11_1
  doi: 10.1016/j.clinbiochem.2016.11.031
– volume: 26
  start-page: 581
  issue: 3
  year: 1971
  ident: e_1_2_9_17_1
  article-title: Circulation et sort du metronidazole dans de tractus digestif chez de rat apres administration par voie orale absorption du metronidazole per les muqueuses digestive
  publication-title: Thérapie
– ident: e_1_2_9_21_1
– ident: e_1_2_9_14_1
  doi: 10.1016/j.jpha.2012.02.007
– ident: e_1_2_9_10_1
  doi: 10.1002/rcm.7158
– ident: e_1_2_9_3_1
  doi: 10.1136/gut.27.10.1169
– ident: e_1_2_9_8_1
– ident: e_1_2_9_13_1
  doi: 10.1136/jcp.34.6.645
– volume: 62
  start-page: 490
  issue: 10
  year: 2012
  ident: e_1_2_9_5_1
  article-title: Metronidazole immediate release formulations: a fasting randomized open‐label crossover bioequivalence study in healthy volunteers
  publication-title: Arzneimittel‐Forschung
– volume: 59
  start-page: 327
  issue: 5
  year: 2002
  ident: e_1_2_9_12_1
  article-title: A simple and rapid liquid chromatographic method for the determination of metronidazole and its hydroxymetabolite in plasma and cutaneous microdialysates
  publication-title: Acta Poloniae Pharmaceutica
– ident: e_1_2_9_9_1
  doi: 10.1016/S0378-4347(98)00443-5
– ident: e_1_2_9_23_1
  doi: 10.1002/bmc.4242
– ident: e_1_2_9_16_1
  doi: 10.1016/j.jpba.2004.11.042
– ident: e_1_2_9_24_1
  doi: 10.1016/S0378-4347(01)00334-6
– ident: e_1_2_9_22_1
– ident: e_1_2_9_6_1
  doi: 10.2147/IDR.S119571
– ident: e_1_2_9_4_1
  doi: 10.1080/10826070903430381
– volume: 14
  start-page: 15
  issue: 1
  year: 2006
  ident: e_1_2_9_7_1
  article-title: A rapid and sensitive HPLC method for the analysis of metronidazole in human plasma: Application to single dose pharmacokinetic and bioequivalence studies
  publication-title: DARU Journal of Pharmaceutical Sciences
– ident: e_1_2_9_20_1
  doi: 10.1093/chromsci/47.9.781
– ident: e_1_2_9_18_1
  doi: 10.1016/j.jpba.2004.12.033
– ident: e_1_2_9_19_1
  doi: 10.1016/j.microc.2017.08.008
– ident: e_1_2_9_2_1
  doi: 10.2147/CIA.S149089
SSID ssj0009627
Score 2.2029016
Snippet A highly selective and sensitive liquid chromatography–tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ)...
A highly selective and sensitive liquid chromatography-tandem mass spectrometry (LC MS/MS) method was developed for the quantification of metronidazole (MTZ)...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e4265
SubjectTerms healthy subjects
human feces
LC–MS/MS
metronidazole
metronidazole‐d4
sensitive
Title Quantification of metronidazole in healthy subjects' feces using an LC–MS/MS method
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbmc.4265
https://www.ncbi.nlm.nih.gov/pubmed/29679499
https://www.proquest.com/docview/2028950503
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6hHoALlC2PpYCMhNpTdjeJvXGOZUVVIYIEZaVKHKKxY1eIbhaxm0N74j_wD_tLOhMnW5WHhDhEudhW4rE93zz8DcArjVbFXuloYjOMpPNZhBJNlBjSbmQ_E6DjiG7xfno0l29P1EmXVcl3YQI_xMbhxjujPa95g6NZja9JQ83Cjki98P1yTtViPPTxmjmKa8oE90rO9LF5zzs7ScZ9x5ua6Dd4eROtturm8D587j80ZJl8HTVrM7IXv3A4_t-fbMO9DoWKg7BsHsAtVw9g56AmC3xxLvZEmxfaOtwHcGfW14QbwO2iC8XvwPxDgyHRqJWtWHqxcG1BnQovlmdOfKlFuGR5LlaNYXfPal94R-eS4GT7U4G1eDe7_PGzOB4XxyKUsn4I88M3n2ZHUVejIbIpoYUolWS_OHoSO9WumsY6wwwr57RGnbo8R5lNLE50ZbxNbG4zSyaer8gywzhVmD6CrXpZuycgYu2VJXjocuWkkh4NOlnlsfKZJFyXDGG_l1dpOwJzrqNxVgbq5aSkiSx5IofwctPyWyDt-FObXuQlTSKHSbB2y2ZVJhx8VcyTM4THYS1sRknyacZ0PkPYayX61-HL18WM30__teEu3CUspkP62jPYWn9v3HPCO2vzol3ZVypm-04
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4aQ2K8cOm4lKuR0PaUtknsxhFPozAVaCbBVmkPk6ITx0aINUW0edie-A_8Q34J58RNp3GREA9RXhwr8bHj71z8fQDPNRoVOqWDgUkwkNYlAUosgqig3Y38ZwJ0nNHNDobjqXx7rI434EV7FsbzQ6wDbrwymv81L3AOSPcvWEOLmenR_qKuwFUW9Gb5glcfLrijWFXGB1hSJpBNW-bZQdRvn7y8F_0GMC_j1WbD2b8JJ-2r-jqTz716WfTM-S8sjv_5LbfgxgqIij0_c27Dhq06sL1XkRM-OxM7oikNbWLuHdgatbJwHbiWrbLx2zB9X6OvNWrMK-ZOzGyjqVPi-fzUik-V8Ocsz8SiLjjis9gVztKvSXC9_UeBlZiMfnz7nh32s0Ph1azvwHT_9dFoHKxkGgITE2AIYkkujKUrMkNty2GoE0ywtFZr1LFNU5TJwOBAl4UzkUlNYsjLcyU5ZxjGCuO7sFnNK3sfRKidMoQQbaqsVNJhgVaWaahcIgnaRV3YbQ2WmxWHOUtpnOaefTnKaSBzHsguPFu3_OJ5O_7UprV5ToPImRKs7Lxe5BHnXxVT5XThnp8M616idJgwo08XdhqT_rX7_GU24vuDf234FLbGR9kkn7w5ePcQrhM0076a7RFsLr_W9jHBn2XxpJnmPwHT8P9o
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VVipc2rLlZ6EFI6H2lN1NYifOsWy7KtBUQFmpEodo4tgI0c1W3c2hPfEOvGGfhHGcbNUCEuIQ5WJbicf2fPPjbwBeS1TCN0J6AxWjx7WJPeSYe0FO2o3sZwJ0NqKbHkeHY_7uVJw2WZX2Lozjh1g43OzOqM9ru8HPC9O_IQ3NJ6pH6kXcgxUe0V6xgOjTDXWULSrj_CuJ5Y9NWuLZQdBve95WRb_hy9twtdY3o3X40n6pSzP53qvmeU9d3SFx_L9f2YC1BoayPbduHsKSLjuwuVeSCT65ZDusTgytPe4duD9si8J1YDVtYvGbMP5Yocs0qoXLpoZNdF1Rp8Cr6Zlm30rmblleslmVW3_PbJcZTQcTs9n2XxmW7Gh4_eNnetJPT5irZf0IxqODz8NDrynS4KmQ4IIXcjJgND2BiqQuIl_GGGOhtZQoQ50kyOOBwoEscqMClahYkY1nCjLN0A8Fho9huZyW-ikwXxqhCB_qRGguuMEcNS8SX5iYE7ALurDbyitTDYO5LaRxljnu5SCjiczsRHbh1aLluWPt-FObVuQZTaKNk2Cpp9UsC2z0VViinC48cWthMUqQRLHl8-nCTi3Rvw6fvUmH9v3sXxu-hNUP-6Ps6O3x--fwgHCZdKlsW7A8v6j0NmGfef6iXuS_APWi_iA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+metronidazole+in+healthy+subjects%27+feces+using+an+LC%E2%80%93MS%2FMS+method&rft.jtitle=Biomedical+chromatography&rft.au=Vanol%2C+Pravin+G.&rft.au=Sanyal%2C+Mallika&rft.au=Shah%2C+Priyanka+A.&rft.au=Shrivastav%2C+Pranav+S.&rft.date=2018-09-01&rft.issn=0269-3879&rft.eissn=1099-0801&rft.volume=32&rft.issue=9&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fbmc.4265&rft.externalDBID=10.1002%252Fbmc.4265&rft.externalDocID=BMC4265
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-3879&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-3879&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-3879&client=summon